logo-loader
viewZilico

Zilicos breaking new ground with a tool to diagnose cervical cancer

"Zilicos CEO Sameer Kothari sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The UK-based company is developing a diagnostic devices to allow for the improvement and extension of clinical screening programs around the world.

Zilico's product portfolio is centered on its patented Electrical Impedance Spectroscopy (EIS) technology. "
 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

HAN-GINS Innovative Technology ETF finds strength in cloud tech, genomics, &...

HAN-GINS Innovative Technology UCITS ETF (LON:ITEK) Founder Anthony Ginsberg discusses key findings within HANetf's recently published 'Monthly Innovative Technology Market Report.' Ginsberg says while the weakest performing subtheme so far within the ETF in 2020 has been future cars and...

17 minutes ago

2 min read